Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Cash Earnings per Share (CEPS)

    Back to All Ratios
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Cash Earnings per Share (CEPS) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   CEPS(Rs) 54.33-44.2617.0052.4650.10

What is the latest Cash Earnings per Share (CEPS) ratio of GLENMARK PHARMACEUTICALS ?

The latest Cash Earnings per Share (CEPS) ratio of GLENMARK PHARMACEUTICALS is 54.33 based on Mar2025 Consolidated results.
Year Cash Earnings per Share (CEPS)
Mar202554.33
Mar2024-44.26
Mar202317.00
Mar202252.46
Mar202150.10

How is Cash Earnings per Share (CEPS) of GLENMARK PHARMACEUTICALS Trending?

Years Cash Earnings per Share (CEPS) % Change
Mar2025 54.33
Positive
Mar2024 -44.26
Negative
Mar2023 17
-67.59
Mar2022 52.46
4.71
Mar2021 50.1 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Cash Earnings per Share (CEPS) ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹61,831.4 Cr -0.1% 1.6% 5.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹480,047.0 Cr 3.1% 7.2% 18.3% Stock Analytics
DIVIS LABORATORIES ₹208,141.0 Cr 8.2% 19.8% 17.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹185,264.0 Cr -1.8% 4.9% 37.2% Stock Analytics
CIPLA ₹118,430.0 Cr 3.9% 0.6% 0% Stock Analytics
DR REDDYS LABORATORIES ₹95,516.1 Cr -0.7% -14.6% -8.4% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-0.1%

1.6%

5.8%

SENSEX

2%

1.9%

-5.2%


You may also like the below Video Courses